• 8002 Citations
  • 43 h-Index
1987 …2020

Research output per year

If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Robert H Collins is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 7 Similar Profiles

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output

Efficacy of ruxolitinib in patients with chronic neutrophilic leukemia and atypical chronic myeloid leukemia

Dao, K. H. T., Gotlib, J., Deininger, M. M. N., Oh, S. T., Cortes, J. E., Collins, R. H., Winton, E. F., Parker, D. R., Lee, H., Schultz, A. R., Stevens, S. S., Brockett, C., Subbiah, N., Press, R. D., Raess, P. W., Cascio, M., Dunlap, J., Chen, Y., Degnin, C., Maxson, J. E. & 4 others, Tognon, C. E., Macey, T., Druker, B. J. & Tyner, J. W., Apr 1 2020, In : Journal of Clinical Oncology. 38, 10, p. 1006-1018 13 p.

Research output: Contribution to journalArticle

  • 1 Scopus citations

    Enasidenib in patients with mutant IDH2 myelodysplastic syndromes: a phase 1 subgroup analysis of the multicentre, AG221-C-001 trial

    Stein, E. M., Fathi, A. T., DiNardo, C. D., Pollyea, D. A., Roboz, G. J., Collins, R., Sekeres, M. A., Stone, R. M., Attar, E. C., Frattini, M. G., Tosolini, A., Xu, Q., See, W. L., MacBeth, K. J., de Botton, S., Tallman, M. S. & Kantarjian, H. M., Apr 2020, In : The Lancet Haematology. 7, 4, p. e309-e319

    Research output: Contribution to journalArticle

  • 2 Scopus citations

    Clinical resistance to crenolanib in acute myeloid leukemia due to diverse molecular mechanisms

    Zhang, H., Savage, S., Schultz, A. R., Bottomly, D., White, L., Segerdell, E., Wilmot, B., McWeeney, S. K., Eide, C. A., Nechiporuk, T., Carlos, A., Henson, R., Lin, C., Searles, R., Ho, H., Lam, Y. L., Sweat, R., Follit, C., Jain, V., Lind, E. & 10 others, Borthakur, G., Garcia-Manero, G., Ravandi, F., Kantarjian, H. M., Cortes, J., Collins, R. H., Buelow, D. R., Baker, S. D., Druker, B. J. & Tyner, J. W., Dec 1 2019, In : Nature communications. 10, 1, 244.

    Research output: Contribution to journalArticle

    Open Access
  • 19 Scopus citations

    Enasidenib, an inhibitor of mutant IDH2 proteins, induces durable remissions in older patients with newly diagnosed acute myeloid leukemia

    Pollyea, D. A., Tallman, M. S., de Botton, S., Kantarjian, H. M., Collins, R., Stein, A. S., Frattini, M. G., Xu, Q., Tosolini, A., See, W. L., MacBeth, K. J., Agresta, S. V., Attar, E. C., DiNardo, C. D. & Stein, E. M., Nov 1 2019, In : Leukemia. 33, 11, p. 2575-2584 10 p.

    Research output: Contribution to journalArticle

    Open Access
  • 17 Scopus citations

    Genomic landscape of neutrophilic leukemias of ambiguous diagnosis

    Zhang, H., Wilmot, B., Bottomly, D., Dao, K. H. T., Stevens, E., Eide, C. A., Khanna, V., Rofelty, A., Savage, S., Schultz, A. R., Long, N., White, L., Carlos, A., Henson, R., Lin, C., Searles, R., Collins, R. H., DeAngelo, D. J., Deininger, M. W., Dunn, T. & 12 others, Hein, T., Luskin, M. R., Medeiros, B. C., Oh, S. T., Pollyea, D. A., Steensma, D. P., Stone, R. M., Druker, B. J., McWeeney, S. K., Maxson, J. E., Gotlib, J. R. & Tyner, J. W., Sep 12 2019, In : Blood. 134, 11, p. 867-879 13 p.

    Research output: Contribution to journalArticle

  • 7 Scopus citations